Covered recipient · General Payments record
GILBERT SNIDER
General Payments · PY2018–2022
$2,551.52
- Reported across 123 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $372.71 | 15 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Biogen, Inc. | $95.36 | 4 |
| ABBVIE INC. | $49.64 | 2 |
| Amgen Inc. | $39.89 | 1 |
| Alexion Pharmaceuticals, Inc. | $36.13 | 2 |
| UCB, Inc. | $32.41 | 1 |
| GENZYME CORPORATION | $28.68 | 1 |
| Lundbeck LLC | $26.39 | 1 |
| IMPEL PHARMACEUTICALS INC. | $22.83 | 1 |
| E.R. Squibb & Sons, L.L.C. | $22.47 | 1 |
| Janssen Pharmaceuticals, Inc | $18.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.87 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891633383 | CMS |
| ABBVIE INC. | $24.77 | 03/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891633385 | CMS |
| Alexion Pharmaceuticals, Inc. | $17.78 | 04/06/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920232159 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.35 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920245019 | CMS |
| Amgen Inc. | $39.89 | 06/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939267695 | CMS |
| Biogen, Inc. | $11.86 | 01/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923420769 | CMS |
| Biogen, Inc. | $29.27 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923391485 | CMS |
| Biogen, Inc. | $26.05 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923394169 | CMS |
| Biogen, Inc. | $28.18 | 09/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923450207 | CMS |
| E.R. Squibb & Sons, L.L.C. | $22.47 | 03/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | 932909153 | CMS |
| GENZYME CORPORATION | $28.68 | 05/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 938754809 | CMS |
| IMPEL PHARMACEUTICALS INC. | $22.83 | 06/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | 962313941 | CMS |
| Janssen Pharmaceuticals, Inc | $18.91 | 05/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 886962033 | CMS |
| Lundbeck LLC | $26.39 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 945804601 | CMS |
| UCB, Inc. | $32.41 | 03/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 907977907 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.